North America Cancer Vaccines Market- Growth, Trends, and Forecasts (2020–2025)

The North America Cancer Vaccines Market is segmented by Technology, Treatment Method (Preventive Vaccine and Therapeutic Vaccine), Application, Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

12.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North America Cancer Vaccines Market is expected to grow with a CAGR of 12.2% in the forecast period. The key factors propelling the growth of the market are the increasing number of cancer cases, rising investments and government funding in the development of cancer vaccines, and technological developments in cancer vaccines. 

The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. According to the American Cancer Society, cancer is the leading cause of death in Canada and the second-leading cause, in the United States. Around 1.9 million new cancer cases and 693,000 cancer deaths were recorded in Northern America in 2018. The number is estimated to increase in the coming years due to the changing lifestyle of the people found in the region. Therefore with the increasing prevalence of cancer, the market is expected to grow.

Scope of the report

As per the scope of the report, cancer vaccines are defined as the vaccines developed to prevent or treat existing cancers, by strengthening the body’s natural immune response system against cancer. These cancer vaccines belong to a class of substances, known as biological response modifiers. These modifiers work by stimulating or restoring the immune system’s ability to fight against diseases.

By Technology
Recombinant Cancer Vaccines
Whole-cell Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Other Technologies
By Treatment Method
Preventive Vaccine
Therapeutic Vaccine
By Application
Prostate Cancer
Cervical Cancer
Other Applications
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

Key Market Trends

Preventive Vaccines are Expected to a Hold Significant Market Share in the Treatment Method

Preventive vaccines or prophylactic vaccines are the vaccines intended to prevent cancer in healthy people. These vaccines work by preventing infectious agents that cause or contribute to the development of cancer. These vaccines are similar to traditional vaccines that help prevent infectious diseases, such as polio and measles, by protecting the body against infections. Most of the preventive vaccines stimulate the production of antibodies, which bind to specifically targeted microbes and block their ability to cause infection.

For instance, the HPV vaccine protects against the types of HPV that most often cause cancers. According to the Centers for Disease Control and Prevention, 2019, HPV vaccines are recommended for teenagers to prevent HPV related cancers. Moreover, the demand for these vaccines is expected to increase due to the rising incidence of cancer in North America.

To understand key trends, Download Sample Report

Competitive Landscape

The North America Cancer Vaccines Market is s highly competitive and consists of a few major players. Companies, like, Bristol-Myers Squibb, Amgen Inc, GlaxoSmithKline, Merck & Co. Inc., OSE Immunotherapeutics, Sanofi, among others, hold substantial shares in the cancer vaccines market.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Cancer Cases

      2. 4.2.2 Rising Investments and Government Funding in the Development of Cancer Vaccines

      3. 4.2.3 Technological Developments in Cancer Vaccines

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Guidelines and Longer Timelines Required for Manufacturing Process

      2. 4.3.2 Presence of Alternative Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 Recombinant Cancer Vaccines

      2. 5.1.2 Whole-cell Cancer Vaccines

      3. 5.1.3 Viral Vector and DNA Cancer Vaccines

      4. 5.1.4 Other Technologies

    2. 5.2 By Treatment Method

      1. 5.2.1 Preventive Vaccine

      2. 5.2.2 Therapeutic Vaccine

    3. 5.3 By Application

      1. 5.3.1 Prostate Cancer

      2. 5.3.2 Cervical Cancer

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Astellas Pharma Inc.

      2. 6.1.2 Merck & Co. Inc.

      3. 6.1.3 GlaxoSmithKline PLC

      4. 6.1.4 Bristol-Myers Squibb

      5. 6.1.5 Dendreon

      6. 6.1.6 Aduro BioTech Inc.

      7. 6.1.7 Sanofi SA

      8. 6.1.8 Amgen Inc.

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports